MedPath
HSA Approval

ORCIGESIC CAPSULE

SIN07108P

ORCIGESIC CAPSULE

ORCIGESIC CAPSULE

July 10, 1992

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

CAPSULE

ORAL

Medical Information

M01AG01

mefenamic acid

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

ORPHENADRINE CITRATE

35 mg

Orphenadrine

MEFENAMIC ACID

250 mg

Mefenamic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORCIGESIC CAPSULE - HSA Approval | MedPath